ArticleEmerging infectious diseases2004
Wrestling SARS from uncertainty.
Article in Emerging infectious diseases, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- The antiviral action of common household disinfectants and antiseptics against murine hepatitis virus, a potential surrogate for SARS coronavirus.American journal of infection control · 2009Article
- Procyanidins and butanol extract of Cinnamomi Cortex inhibit SARS-CoV infection.Antiviral research · 2009Article
- Emerging and reemerging diseases: a historical perspective.Immunological reviews · 2008Review
- Optimal and sub-optimal quarantine and isolation control in SARS epidemics.Mathematical and computer modelling · 2008Article
- Preparations and limitations for prevention of severe acute respiratory syndrome in a tertiary care centre of India.The Journal of hospital infection · 2007Article
- Changes in attitudes toward wildlife and wildlife meats in Hunan Province, central China, before and after the severe acute respiratory syndrome outbreak.Integrative zoology · 2007Article
- Anti-SARS-CoV immunoglobulin G in healthcare workers, Guangzhou, China.Emerging infectious diseases · 2005Article
- A novel cell-based binding assay system reconstituting interaction between SARS-CoV S protein and its cellular receptor.Journal of virological methods · 2005Article
- Demand for nonhuman primate resources in the age of biodefense.ILAR journal · 2005Review
- Modelling strategies for minimizing the impact of an imported exotic infection.Proceedings. Biological sciences · 2004Article
- Modelling strategies for controlling SARS outbreaks.Proceedings. Biological sciences · 2004Article
- Severe acute respiratory syndrome and tuberculosis.Anesthesiology clinics of North America · 2004Review
- SARS outbreak in Taiwan.Emerging infectious diseases · 2004Article
- What have we learnt from SARS?Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2004Article
- Immunofluorescence assay for serologic diagnosis of SARS.Emerging infectious diseases · 2004Article
- Risk factors for SARS among persons without known contact with SARS patients, Beijing, China.Emerging infectious diseases · 2004Article
- Atypical SARS and Escherichia coli bacteremia.Emerging infectious diseases · 2004Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.